Haleon PLC — Investor Relations & Filings
Haleon PLC is a global consumer healthcare company focused on improving everyday health. The company develops and markets a portfolio of category-leading brands built on scientific innovation and trusted by consumers and healthcare professionals. Its product offerings span several key categories, including Oral Health, Pain Relief, Respiratory Health, and Vitamins, Minerals, and Supplements. Notable brands within its portfolio include Sensodyne, Advil, Voltaren, and Centrum. Haleon's mission is to deliver better everyday health with humanity, making it more achievable, inclusive, and sustainable.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| HALEON 2025 Q3 TRADING STATEMENT | 2025-10-30 | English | |
| Haleon 2025 Q3 Trading Statement | 2025-10-30 | English | |
| Haleon 2025 Q3 Trading Statement | 2025-10-30 | English | |
| DIRECTOR/PDMR SHAREHOLDING | 2025-10-10 | English | |
| Director/PDMR Shareholding | 2025-10-10 | English | |
| DIRECTOR DECLARATION | 2025-10-02 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 13562303 | HALEON 2025 Q3 TRADING STATEMENT | 2025-10-30 | English | ||
| 8058776 | Haleon 2025 Q3 Trading Statement | 2025-10-30 | English | ||
| 8062443 | Haleon 2025 Q3 Trading Statement | 2025-10-30 | English | ||
| 13562306 | DIRECTOR/PDMR SHAREHOLDING | 2025-10-10 | English | ||
| 7995700 | Director/PDMR Shareholding | 2025-10-10 | English | ||
| 13562318 | DIRECTOR DECLARATION | 2025-10-02 | English | ||
| 13562304 | TRANSACTION IN OWN SHARES & BUYBACK UPDATE | 2025-10-02 | English | ||
| 7947545 | Director Declaration | 2025-10-02 | English | ||
| 7947146 | Transaction in Own Shares & Buyback Update | 2025-10-02 | English | ||
| 13562305 | TOTAL VOTING RIGHTS AND CAPITAL | 2025-10-01 | English | ||
| 13562307 | TRANSACTION IN OWN SHARES | 2025-10-01 | English | ||
| 7944602 | Total Voting Rights and Capital | 2025-10-01 | English | ||
| 7943692 | Transaction in Own Shares | 2025-10-01 | English | ||
| 13562308 | TRANSACTION IN OWN SHARES | 2025-09-30 | English | ||
| 11392034 | Transaction in Own Shares | 2025-09-30 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Haleon PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Haleon PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/5111/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=5111 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=5111 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=5111 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 5111}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Haleon PLC (id: 5111)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.